|
JP5566880B2
(ja)
*
|
2007-04-24 |
2014-08-06 |
インゲニウム ファーマシューティカルズ ジーエムビーエイチ |
プロテインキナーゼの阻害剤としての４，６−二置換アミノピリミジン誘導体
|
|
US8389521B2
(en)
*
|
2007-04-24 |
2013-03-05 |
Ingenium Pharmaceuticals Gmbh |
Inhibitors of protein kinases
|
|
WO2008129070A1
(en)
|
2007-04-24 |
2008-10-30 |
Ingenium Pharmaceuticals Gmbh |
Inhibitors of protein kinases
|
|
CN102481327B
(zh)
*
|
2009-07-08 |
2015-01-28 |
乔本生医股份有限公司 |
一种龙眼核萃取物的制备方法与应用
|
|
JP2013107824A
(ja)
*
|
2010-03-17 |
2013-06-06 |
Dainippon Sumitomo Pharma Co Ltd |
新規単環ピリミジン誘導体
|
|
EA026917B1
(ru)
*
|
2010-03-22 |
2017-05-31 |
Лид Дискавери Сентр Гмбх |
Фармацевтически активные производные двузамещенного триазина
|
|
WO2012066065A1
(en)
*
|
2010-11-17 |
2012-05-24 |
Novartis Ag |
Phenyl-heteroaryl amine compounds and their uses
|
|
EP2681193B1
(en)
*
|
2011-03-02 |
2016-01-06 |
Lead Discovery Center GmbH |
Pharmaceutically active disubstituted pyridine derivatives
|
|
US9226929B2
(en)
|
2011-03-02 |
2016-01-05 |
Bayer Intellectual Property Gmbh |
Pharmaceutically active disubstituted triazine derivatives
|
|
CN103476759B
(zh)
*
|
2011-04-19 |
2016-03-16 |
拜耳知识产权有限责任公司 |
取代的4-芳基-n-苯基-1,3,5-三嗪-2-胺
|
|
EP2527332A1
(en)
|
2011-05-24 |
2012-11-28 |
Bayer Intellectual Property GmbH |
4-Aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group as CDK9 inhibitors
|
|
TW201636330A
(zh)
|
2011-05-24 |
2016-10-16 |
拜耳知識產權公司 |
含有硫醯亞胺基團之４－芳基－ｎ－苯基－１，３，５－三氮雜苯－２－胺
|
|
WO2013037896A1
(en)
|
2011-09-16 |
2013-03-21 |
Bayer Intellectual Property Gmbh |
Disubstituted 5-fluoro-pyrimidines
|
|
EP2755948B1
(en)
|
2011-09-16 |
2016-05-25 |
Bayer Intellectual Property GmbH |
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group
|
|
HK1209414A1
(en)
|
2012-10-18 |
2016-04-01 |
Bayer Pharma Aktiengesellschaft |
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
|
|
CN105102434A
(zh)
*
|
2012-10-18 |
2015-11-25 |
拜耳药业股份公司 |
含砜基团的4-(邻)-氟苯基-5-氟嘧啶-2-基胺
|
|
JP6277196B2
(ja)
*
|
2012-10-18 |
2018-02-07 |
バイエル ファーマ アクチエンゲゼルシャフト |
スルホン基を含んでいるｎ−（ピリジン−２−イル）ピリミジン−４−アミン誘導体
|
|
JP6300818B2
(ja)
*
|
2012-11-15 |
2018-03-28 |
バイエル ファーマ アクチエンゲゼルシャフト |
スルホキシイミン基を含有する４−（オルト）−フルオロフェニル−５−フルオロピリミジン−２−イルアミン
|
|
TW201418243A
(zh)
|
2012-11-15 |
2014-05-16 |
Bayer Pharma AG |
含有磺醯亞胺基團之ｎ－（吡啶－２－基）嘧啶－４－胺衍生物
|
|
MA38090B1
(fr)
|
2012-11-15 |
2018-09-28 |
Bayer Pharma AG |
Dérivés de 5-fluoro-n-(pyridin -2-yl)pyridin-2-amines contenant un groupe sulfoximine
|
|
CN105492438B
(zh)
|
2013-07-04 |
2018-08-07 |
拜耳医药股份有限公司 |
磺亚胺取代的5-氟-n-(吡啶-2-基)吡啶-2-胺衍生物以及其作为cdk9激酶抑制剂的用途
|
|
US9856242B2
(en)
|
2014-03-13 |
2018-01-02 |
Bayer Pharma Aktiengesellscaft |
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
|
|
US9790189B2
(en)
|
2014-04-01 |
2017-10-17 |
Bayer Pharma Aktiengesellschaft |
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group
|
|
TN2016000435A1
(en)
|
2014-04-11 |
2018-04-04 |
Bayer Pharma AG |
Novel macrocyclic compounds.
|
|
EP3207038B1
(en)
|
2014-10-16 |
2018-08-22 |
Bayer Pharma Aktiengesellschaft |
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfoximine group
|
|
WO2016059011A1
(en)
|
2014-10-16 |
2016-04-21 |
Bayer Pharma Aktiengesellschaft |
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone group
|
|
CN107428707A
(zh)
|
2015-03-24 |
2017-12-01 |
拜耳制药股份公司 |
4‑(4‑氟‑2‑甲氧基苯基)‑n‑{3‑[(s‑甲基亚磺酰亚胺基)甲基]苯基}‑1,3,5‑三嗪‑2‑胺用于治疗多发性骨髓瘤的用途
|
|
WO2016150902A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating gastric cancers
|
|
EP3273963A1
(en)
|
2015-03-24 |
2018-01-31 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating lymphomas
|
|
JP6997627B2
(ja)
|
2015-06-29 |
2022-01-17 |
アストラゼネカ・アクチエボラーグ |
Ｃｄｋ９阻害剤としての多環式アミド誘導体
|
|
US10717749B2
(en)
|
2015-09-29 |
2020-07-21 |
Bayer Pharma Aktiengesellschaft |
Macrocyclic sulfondiimine compounds
|
|
JP6888000B2
(ja)
|
2015-10-08 |
2021-06-16 |
バイエル ファーマ アクチエンゲゼルシャフト |
新規な修飾された大環状化合物
|
|
WO2017060322A2
(en)
|
2015-10-10 |
2017-04-13 |
Bayer Pharma Aktiengesellschaft |
Ptefb-inhibitor-adc
|
|
EP3601253B1
(en)
|
2017-03-28 |
2021-09-15 |
Bayer Aktiengesellschaft |
Novel ptefb inhibiting macrocyclic compounds
|
|
CA3057891A1
(en)
|
2017-03-28 |
2018-10-04 |
Bayer Aktiengesellschaft |
Novel ptefb inhibiting macrocyclic compounds
|
|
MA51820A
(fr)
|
2018-02-13 |
2021-05-19 |
Bayer Ag |
Utilisation de 5-fluoro-4-(4-fluoro-2-méthoxyphényl)-n-(4-[(s-méthylsulfonimidoyl)méthyl]pyridin-2-yl)pyridin-2-amine pour traiter un lymphome diffus à grandes cellules b
|
|
EP4129293A4
(en)
*
|
2020-03-27 |
2024-04-03 |
Kyoto University |
INHIBITOR OF NERVE CELL DEGENERATION
|